• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Dept. of Health & Human Services (HHS)

HHS, DOD invest more than $562M to increase COVID-19 test manufacturing

October 22, 2021 By Sean Whooley

The U.S. Department of Health & Human Services (HHS) and Department of Defense (DOD) have awarded more than $562 million for COVID-19 test manufacturing. The funding — part of the American Rescue Plan to boost manufacturing of key products that increase domestic testing supply — went to a dozen U.S. companies to support the production […]

Filed Under: Business/Financial News, Contract Manufacturing, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), U.S. Department of Defense

New BD syringe manufacturing lines are up and running in Nebraska

October 7, 2021 By Sean Whooley

BD (NYSE:BDX) announced today that it increased its manufacturing capacity and domestic supply for syringes and needles. Franklin Lakes, N.J.-based BD’s new syringe and needle manufacturing lines, which were completed on an accelerated timeline, represent BD’s partnership with Department of Health and Human Services’ (HHS) Assistant Secretary for Preparedness and Response (ASPR). Get the full story […]

Filed Under: Business/Financial News, Contract Manufacturing, Drug Pumps, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: BD, becton dickinson, coronavirus, COVID-19, Dept. of Health & Human Services (HHS), U.S. Biomedical Advanced Research and Development Authority (BARDA)

Biden administration invests $3B to accelerate development of next-gen COVID-19 treatments

June 17, 2021 By Chris Newmarker

President Joe Biden’s administration will spend $3 billion in American Rescue Plan money to accelerate the discovery, development and manufacturing of antiviral medicines against COVID-19, HHS announced today. Not only will the  Antiviral Program for Pandemics seek to boost the availability of medicines to prevent serious COVID-19 illness and save lives, but it will pursue […]

Filed Under: Business/Financial News, Featured, Pharmaceutical, Research & Development Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), HHS, Joe Biden

HHS wants investors to help prevent next pandemic

June 3, 2021 By Nancy Crotti

The U.S. Department of Health and Human Services (HHS) is turning to venture capital to speed the development of medical devices to stave off or fight public health emergencies. HHS’s Biomedical Advanced Research and Development Authority (BARDA) plans to provide the nonprofit Global Health Investment Corporation (GHIC) with a minimum of $50 million over five years, with […]

Filed Under: Business/Financial News, Funding Roundup Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Global Health Investment Corporation, U.S. Biomedical Advanced Research and Development Authority (BARDA)

Senate confirms new CMS leader

May 25, 2021 By Sean Whooley

The U.S. Senate today confirmed President Joe Biden’s selection to lead CMS, Chiquita Brooks-LaSure, with a 55-44 vote in favor. Brooks-LaSure will be the first Black woman to hold the position, according to Senate Majority Leader Chuck Schumer (D-N.Y.) on Twitter. She previously served in the U.S. Dept. of Health and Human Services during the […]

Filed Under: Business/Financial News, Featured, Healthcare Reform, Legal News, Medicare Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, Dept. of Health & Human Services (HHS), Joe Biden

HHS shoots down ‘flawed’ plan to let some devices skip review

April 15, 2021 By Nancy Crotti

The Biden administration has nixed what it described as a “flawed” Trump-era decision to exempt certain medical devices — including infusion pump controllers and fetal monitors — from regulatory review. HHS published the original notice in the Federal Register on Jan. 15, shortly before President Joe Biden was set to take office, without speaking with […]

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Dept. of Health & Human Services (HHS), FDA

Companies, docs alarmed by proposed 510(k) rollback

March 23, 2021 By Nancy Crotti

Medical associations and device companies have largely come out against a Trump administration proposal to permanently exempt certain medical devices and software from the FDA 510(k) clearance process. HHS used Trump’s waning days in office to propose permanently exempting 83 Class II devices and one unclassified device from the clearance review process. The list includes home ventilators, […]

Filed Under: 510(k), Diagnostics, Featured, Food & Drug Administration (FDA), Imaging, Regulatory/Compliance Tagged With: AliveCor, Baxter, Caption Health, Dept. of Health & Human Services (HHS), FDA, Mayo Clinic, Roche

Xavier Becerra confirmed as HHS secretary

March 18, 2021 By Sean Whooley

The U.S. Senate narrowly voted to confirm Xavier Becerra as the U.S. Dept. of Health & Human Services (HHS) secretary today. Becerra received the nomination for the position from President Joe Biden in December 2020. Today, the Senate voted 50-49 in favor of Becerra, who will have to resign his seat as California’s attorney general. […]

Filed Under: Business/Financial News, Featured, Healthcare Reform, Medicare, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), HHS, Joe Biden, U.S. Senate

Biden to put $12B toward COVID testing

March 17, 2021 By Nancy Crotti

The Biden administration today pledged $10 billion for school COVID-19 screenings and $2.25 billion for screenings and diagnostic testing among underserved populations. The money is part of the $1.9 trillion American Rescue Plan Act that Biden signed into law last week. The Department of Health and Human Services will divvy up the $10 billion among […]

Filed Under: Business/Financial News, Diagnostics, Distribution, Featured Tagged With: AdvaMed, Centers for Disease Control & Prevention (CDC), coronavirus, COVID-19, Dept. of Health & Human Services (HHS), FDA, Joe Biden

Feds to spend $1.6B to expand COVID testing, domestic manufacturing

February 17, 2021 By Nancy Crotti

The Biden administration announced plans today to expand COVID-19 testing across the country, boost domestic manufacturing of tests and testing supplies and increase virus genome sequencing to detect virus variants. The departments of Health and Human Services and Defense will jointly invest $650 million to expand testing for K-8 schools and underserved congregate settings, such […]

Filed Under: Business/Financial News, Diagnostics, Featured, Lab Instruments & Supplies Tagged With: AdvaMed, coronavirus, COVID-19, COVID-19 variants, Dept. of Health & Human Services (HHS), U.S. Centers for Disease Control and Prevention (CDC), U.S. Department of Defense

Retractable Technologies lands $54.2M federal contract for syringes

February 17, 2021 By Sean Whooley

Retractable Technologies (NYSE:RVP) announced that it received a government contract worth more than $54.2 million for its syringes. Little Elm, Texas-based Retractable Technologies’ contract and purchase order was made by the U.S. Health & Human Services Dept. (HHS) with a base price of $54,217,800 for a five-month period between Feb. 15, 2021, and July 14, 2021. […]

Filed Under: Business/Financial News, Contract Manufacturing, Drug-Device Combinations, Featured, Funding Roundup Tagged With: Dept. of Health & Human Services (HHS), Retractable Technologies Inc.

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 15
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy